Welcome to the ValueWiki TISSUE THERAPIES LIMITED (TIS.AX) article! Register for free or click the "edit" link to contribute!
TISSUE THERAPIES LIMITED (TIS.AX)
From ValueWiki
Business Description from asx.com.au: Developing biomedical technologies for wound healing and tissue and cell culture.[1]
You can add information to this page! Just click any blue [ edit ] link to contribute.
[edit]
Company Analysis
You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.
The edit window has shortcut and help links if you need them.[2] Be bold!
[edit]
News Feed
[edit]
Leadership
- TISSUE THERAPIES LIMITED Executive Information
- TISSUE THERAPIES LIMITED Directors / Senior Management[1]
Mr Roger Clarke (Chairman) Dr Steven Mercer (Director, CEO) Mr Gregory Baynton (Executive Director) Prof. David Gardiner (Director) Mr Neil Reinhardt (Director) Mr Don Home (Non Exec. Director)
[edit]
Risks
This section needs content! Click the blue edit link (to the right) to contribute.
[edit]
Research Links
- TISSUE THERAPIES LIMITED Profile
- TISSUE THERAPIES LIMITED Fundamentals
- TISSUE THERAPIES LIMITED Technical Analysis
- TISSUE THERAPIES LIMITED Contact Information[1]
- Website: http://www.tissuetherapies.com
- Address: Level 25, Waterfront Place , 1 Eagle Street , BRISBANE , QLD, AUSTRALIA, 4000
- Phone: (07) 3221 0140
- Fax: (07) 3220 1482
- Share Registry: LINK MARKET SERVICES LIMITED LEVEL 12 , 300 QUEEN STREET , BRISBANE , QLD, AUSTRALIA, 4000
- Share Registry Phone: (02) 8280 7454
- TISSUE THERAPIES LIMITED Message Boards
[edit]
Notes
- ↑ 1.0 1.1 1.2 http://www.asx.com.au/asx/research/CompanyInfoSearchResults.jsp?searchBy=asxCode&allinfo=on&asxCode=TIS ASX.com.au
- ↑ This is a sample reference.










